These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 25514871)
1. Epidermal growth factor receptor variant III renders glioma cancer cells less differentiated by JAGGED1. Kim EJ; Kim SO; Jin X; Ham SW; Kim J; Park JB; Lee JY; Kim SC; Kim H Tumour Biol; 2015 Apr; 36(4):2921-8. PubMed ID: 25514871 [TBL] [Abstract][Full Text] [Related]
2. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation. Yu Y; Zhang Y; Guan W; Huang T; Kang J; Sheng X; Qi J Mol Cancer Res; 2014 Jun; 12(6):830-42. PubMed ID: 24574517 [TBL] [Abstract][Full Text] [Related]
3. High Jagged1 expression is associated with poor outcome in primary glioblastoma. Qiu XX; Wang CH; You N; Chen BJ; Wang XF; Chen YP; Lin ZX Med Oncol; 2015 Jan; 32(1):341. PubMed ID: 25424769 [TBL] [Abstract][Full Text] [Related]
4. Suppression of tongue squamous cell carcinoma growth by inhibition of Jagged1 in vitro and in vivo. Zhang TH; Liu HC; Liang YJ; Liang LZ; Zheng GS; Huang HZ; Wu JN; Liao GQ J Oral Pathol Med; 2013 Apr; 42(4):322-31. PubMed ID: 23157415 [TBL] [Abstract][Full Text] [Related]
5. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019 [TBL] [Abstract][Full Text] [Related]
6. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Purow BW; Haque RM; Noel MW; Su Q; Burdick MJ; Lee J; Sundaresan T; Pastorino S; Park JK; Mikolaenko I; Maric D; Eberhart CG; Fine HA Cancer Res; 2005 Mar; 65(6):2353-63. PubMed ID: 15781650 [TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446 [TBL] [Abstract][Full Text] [Related]
8. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity. Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464 [TBL] [Abstract][Full Text] [Related]
10. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma. Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228 [TBL] [Abstract][Full Text] [Related]
11. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth. Di K; Linskey ME; Bota DA Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488 [TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord epithelial cells express Notch ligands Delta1 and Jagged1. Ng W; Nishiyama C; Mizoguchi M; Ikeda S; Okumura K; Ogawa H J Dermatol Sci; 2009 May; 54(2):131-4. PubMed ID: 19150223 [No Abstract] [Full Text] [Related]
13. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway. Sun HW; Wu C; Tan HY; Wang QS Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917 [TBL] [Abstract][Full Text] [Related]
15. Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling. Hai L; Liu P; Yu S; Yi L; Tao Z; Zhang C; Abeysekera IR; Li T; Tong L; Ma H; Liu B; Xie Y; Zhou X; Lin Y; Zhu M; Zhang K; Ren B; Ming H; Huang Y; Yang X Cell Physiol Biochem; 2018; 51(6):2925-2937. PubMed ID: 30580328 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: implications for targeting Notch signaling. Guilmeau S; Flandez M; Mariadason JM; Augenlicht LH Oncogene; 2010 Feb; 29(7):992-1002. PubMed ID: 19935714 [TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered. Gan HK; Cvrljevic AN; Johns TG FEBS J; 2013 Nov; 280(21):5350-70. PubMed ID: 23777544 [TBL] [Abstract][Full Text] [Related]
19. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma. Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495 [TBL] [Abstract][Full Text] [Related]
20. EGCG attenuates atherosclerosis through the Jagged-1/Notch pathway. Yin J; Huang F; Yi Y; Yin L; Peng D Int J Mol Med; 2016 Feb; 37(2):398-406. PubMed ID: 26648562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]